Evidence map›Paper›PMID 39328799›Full record

ArticleJournal of medical cases2024

Alpha-Fetoprotein-Producing Hepatoid Adenocarcinoma of the Stomach.

Lefika Bathobakae, Mohamed Elagami, Anas Mahmoud, Jaydev Kesrani, Ruhin Yuridullah, Gabriel Melki, Amer Akmal, Yana Cavanagh, Walid Baddoura

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical cases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Lefika BathobakaeInternal Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
Mohamed ElagamiGastroenterology and Hepatology, St. Joseph's University Medical Center, Paterson, NJ, USA.
Anas MahmoudInternal Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
Jaydev KesraniHematology and Oncology, St. Joseph's University Medical Center, Paterson, NJ, USA.
Ruhin YuridullahGastroenterology and Hepatology, St. Joseph's University Medical Center, Paterson, NJ, USA.
Gabriel MelkiGastroenterology and Hepatology, St. Joseph's University Medical Center, Paterson, NJ, USA.
Amer AkmalPathology and Laboratory Medicine, St. Joseph's University Medical Center, Paterson, NJ, USA.
Yana CavanaghGastroenterology and Hepatology, St. Joseph's University Medical Center, Paterson, NJ, USA.
Walid BaddouraGastroenterology and Hepatology, St. Joseph's University Medical Center, Paterson, NJ, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatoid adenocarcinoma of the stomach (HAS) is a rare type of gastric cancer with unique clinicopathological features. HAS has a poor prognosis because of early liver, lung, and lymph node metastasis. Owing to its rarity and malignant potential, data on its pathophysiology and management are scarce. Herein, we describe a case of alpha-fetoprotein-producing HAS (AFP-HAS) with metastases to the liver, lungs, and spine. The patient presented with a 3-month history of epigastric pain and intractable emesis, initially thought to be gastroparesis given her uncontrolled diabetes mellitus. Contrast-enhanced computerized tomography (CECT) of the abdomen and pelvis revealed thickening of the gastric wall with hepatic metastases. Upper endoscopy revealed a fungating gastric mass, and the histopathology confirmed AFP-HAS. The patient did not tolerate palliative chemotherapy and died 6 months after her gastric cancer diagnosis.

Indexed as

Abdominal painAlpha-fetoprotein-producing gastric cancerHepatoid adenocarcinoma of the stomachPalliative chemotherapy

Identifiers

PMID39328799
PMCPMC11424106

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.